Prevalence of Advanced Liver Fibrosis in Patients With Severe Psoriasis
Open Access
- 1 September 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 155 (9) , 1028-1032
Abstract
Liver disease is a leading cause of global morbidity and mortality.1 When liver fibrosis reaches an advanced stage, progression to cirrhosis and hepatocellular carcinoma increases.1 People with psoriasis are more likely than matched controls in the general population to have advanced fibrosis.2 Historically, the cause of liver fibrosis in psoriasis was attributed to methotrexate. Methotrexate has remained the focus of attention in dermatological research and practice. Awareness of other clinical factors that cause liver fibrosis in psoriasis and how best to identify them is limited, which has hindered progress in clinical management.Keywords
This publication has 13 references indexed in Scilit:
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic reviewThe Lancet Gastroenterology & Hepatology, 2017
- Patients with psoriasis are insulin resistantJournal of the American Academy of Dermatology, 2015
- Body mass index, waist circumference and HOMA-IR correlate with the Psoriasis Area and Severity Index in patients with psoriasis receiving phototherapyBritish Journal of Dermatology, 2014
- Liver disease in the UK: a Lancet CommissionThe Lancet, 2013
- The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasisJournal of Gastroenterology, 2012
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in MiceGastroenterology, 2012
- Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control studyJournal of Hepatology, 2010
- Predicting Fibrosis Worsening in Obese Patients With NASH Through Parenchymal Fibronectin, HOMA-IR, and HypertensionAmerican Journal of Gastroenterology, 2010
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985